NCT01103154View on ClinicalTrials.gov

A Trial of Nadolol Plus Isosorbide Mononitrate Versus Carvedilol for the Prevention of Variceal Rebleeding

PHASE4CompletedINTERVENTIONAL
Enrollment

121

Participants

Timeline

Start Date

March 31, 2005

Primary Completion Date

January 31, 2010

Study Completion Date

January 31, 2010

Conditions
Variceal Rebleeding
Interventions
DRUG

carvedilol

6.25mg per day, increase to 6.25mg bid

DRUG

nadolol + ISMN

nadolol 40-80mg ISMN 10-20mg

All Listed Sponsors
collaborator

National Science and Technology Council, Taiwan

OTHER_GOV

lead

E-DA Hospital

OTHER

NCT01103154 - A Trial of Nadolol Plus Isosorbide Mononitrate Versus Carvedilol for the Prevention of Variceal Rebleeding | Biotech Hunter | Biotech Hunter